Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD

Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity

Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors

Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer

Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases

CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL

Managing MCL After BTKi Failure: The Expanding Role of CAR T-Cell Therapy

Reevaluating Race in Spirometry: Advancing Equity in Pulmonary Risk Assessment

Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice

Advancing Precision Medicine in NSCLC: Real-World Impact of the PREDICT Initiative

Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease

CRISPR in Sickle Cell: Transforming Care Through Gene Editing

Evaluating Gene Therapy for Sickle Cell Disease: Advantages and Barriers

Curative Strategies for Sickle Cell Disease: The Future of Gene Editing

Advances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role

Examining Barriers and Facilitators in Pediatric Sickle Cell Disease Care

Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning

Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma

Examining Real-World Ibrutinib Outcomes in R/R MCL: Findings from a Danish Study

Expanding the Risk Profile: Genetic Insights Into Lung Cancer in Non-Smokers